| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/10/2013 | EP2576613A1 Her-2 peptides and vaccines |
| 04/10/2013 | EP2576610A2 Biomarker for diagnosis and treatment of colorectal cancer |
| 04/10/2013 | EP2576597A1 Rhamm binding peptides |
| 04/10/2013 | EP2576596A1 Peptide for use as a medicament, in particular for the treatment of cancer |
| 04/10/2013 | EP2576595A1 Mitochondrial penetrating peptides as carriers for anticancer compounds |
| 04/10/2013 | EP2576592A1 Preparation of crystalline ezatiostat hydrochloride ansolvate form d |
| 04/10/2013 | EP2576591A2 Tablet formulation of ezatiostat |
| 04/10/2013 | EP2576590A1 Crystalline ezatiostat hydrochloride ansolvate |
| 04/10/2013 | EP2576576A1 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
| 04/10/2013 | EP2576568A1 An aminopyrazole triazolothiadiazole inhibitor of c-met protein kinase |
| 04/10/2013 | EP2576566A1 Thieno (2, 3b) pyrazine compounds as b - raf inhibitors |
| 04/10/2013 | EP2576561A1 Heterocyclic compounds as janus kinase inhibitors |
| 04/10/2013 | EP2576552A2 Benzoquinolone inhibitors of vmat2 |
| 04/10/2013 | EP2576544A2 Cytochrome p450 inhibitors and uses thereof |
| 04/10/2013 | EP2576538A1 New ccr2 antagonists |
| 04/10/2013 | EP2576535A1 Combination cancer therapies with wortmannin analogs |
| 04/10/2013 | EP2576532A1 Furanyl compounds and the use thereof |
| 04/10/2013 | EP2576514A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors |
| 04/10/2013 | EP2576513A1 Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases |
| 04/10/2013 | EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 04/10/2013 | EP2575880A2 Monoclonal antibodies against her2 epitope |
| 04/10/2013 | EP2575879A1 Novel anti-cmet antibody |
| 04/10/2013 | EP2575876A1 Multivalent synthetic nanocarrier vaccines |
| 04/10/2013 | EP2575863A2 Use of the sparc microenvironment signature in the treatment of cancer |
| 04/10/2013 | EP2575856A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
| 04/10/2013 | EP2575851A1 Novel anticancer agents comprising peptides with cancer-specific toxicity |
| 04/10/2013 | EP2575850A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 04/10/2013 | EP2575823A1 3-substituted vinylboronates and uses thereof |
| 04/10/2013 | EP2575818A2 The use of inhibitors of bruton's tyrosine kinase (btk) |
| 04/10/2013 | EP2575810A1 Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor |
| 04/10/2013 | EP2575804A1 Methods of treatment of pancreatic cancer |
| 04/10/2013 | EP2575803A1 Methods of treating bladder cancer |
| 04/10/2013 | EP2575802A1 Phosphaplatins and their use for treatment of cancers |
| 04/10/2013 | EP2575801A1 Novel iridium/rhodium anti-cancer compounds |
| 04/10/2013 | EP2575800A1 Rhenium complexes and their pharmaceutical use. |
| 04/10/2013 | EP2575792A1 Biguanide compounds and its use for treating cancer |
| 04/10/2013 | EP2575774A1 Combination therapy methods for treating proliferative diseases |
| 04/10/2013 | EP2575773A2 Synthetic nanocarrier combination vaccines |
| 04/10/2013 | EP2575763A2 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 04/10/2013 | EP2575474A1 Methods for increasing the production or activity of catalase |
| 04/10/2013 | EP2575466A1 Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin |
| 04/10/2013 | EP2575460A1 Combination |
| 04/10/2013 | EP2575459A1 Cancer treatment with wortmannin analogs |
| 04/10/2013 | EP2575458A1 Tocotrienol compositions |
| 04/10/2013 | CN103038258A Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LRP6) antibodies |
| 04/10/2013 | CN103038248A RHAMM binding peptides |
| 04/10/2013 | CN103038239A Crystalline forms of kinase inhibitors |
| 04/10/2013 | CN103038233A Pyridone and aza-pyridone compounds and methods of use |
| 04/10/2013 | CN103038231A Modulators of HEC1 activity and methods therefor |
| 04/10/2013 | CN103038227A Nilotinib salts and crystalline forms thereof |
| 04/10/2013 | CN103038221A Chk-1 activity regulator |
| 04/10/2013 | CN103038216A Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases |
| 04/10/2013 | CN103037896A The N-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 04/10/2013 | CN103037888A Treatment of proliferative diseases |
| 04/10/2013 | CN103037879A Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 04/10/2013 | CN103037862A Methods of treating or preventing estrogen-related diseases |
| 04/10/2013 | CN103037859A Phosphaplatins and their use for treatment of cancers |
| 04/10/2013 | CN103037855A Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer |
| 04/10/2013 | CN103037846A Combination therapy methods for treating proliferative diseases |
| 04/10/2013 | CN103037840A Lipid membrane structure with nuclear transferability |
| 04/10/2013 | CN103031334A Dual-target siRNA eukaryotic expression plasmid capable of inhibiting STAT3 and AFP gene expression, and application of expression plasmid |
| 04/10/2013 | CN103030738A Lawsone copolymer with antineoplastic activity and preparation method thereof |
| 04/10/2013 | CN103030695A Anti c-met humanized antibody and uses thereof |
| 04/10/2013 | CN103030688A Short chain polypeptide for inhibiting cancer cell growth as well as encoding gene and application of short chain polypeptide |
| 04/10/2013 | CN103030684A Novel bleomycin analogue as well as preparation method and application thereof |
| 04/10/2013 | CN103030683A Peptaibol and preparation method and use thereof |
| 04/10/2013 | CN103030678A Method for preparing rare ginsenoside from malonyl ginsenoside |
| 04/10/2013 | CN103030654A Micromolecular c-Met protein kinase inhibitor |
| 04/10/2013 | CN103030653A Heteroarylopyrimidine derivative, medicinal salt thereof, methods for preparing heteroarylopyrimidine derivative and medicinal salt thereof and medical applications of heteroarylopyrimidine derivative and medicinal salt thereof |
| 04/10/2013 | CN103030637A Imidazole quinoline derivative, and pharmaceutically acceptable salts thereof, preparation method thereof and application thereof on medicines |
| 04/10/2013 | CN103030597A Kidney type glutaminase inhibitor as well as preparation method and application kidney type glutaminase inhibitor |
| 04/10/2013 | CN103030589A N-(4-fluorobenzyl)-3, 5-bis(4-trifluoromethyl benzylidene)-4-piperodone and preparation as well as application |
| 04/10/2013 | CN103030549A P-benzoquinone derivative and application thereof |
| 04/10/2013 | CN103030140A Oxidized graphene modified by hyaluronic acid and preparation method and application of medicinal composition of oxidized graphene modified by hyaluronic acid |
| 04/10/2013 | CN103028120A Compositions and methods for the diagnosis and therapy of BCL2-associated cancers |
| 04/10/2013 | CN103028087A Traditional Chinese medicine composition for treating rectal cancer |
| 04/10/2013 | CN103028085A Traditional Chinese medicine preparation for treating cutaneous hemangioma |
| 04/10/2013 | CN103028079A Pharmaceutical composition for preventing and treating brain tumor and preparation method |
| 04/10/2013 | CN103028077A Traditional Chinese medicine preparation for treating tumors |
| 04/10/2013 | CN103028073A Preparation method of traditional Chinese medicine prescription for treating esophagus cancer |
| 04/10/2013 | CN103028059A Traditional Chinese medicine composition for treating cholangiocarcinoma |
| 04/10/2013 | CN103028028A Traditional Chinese medicine agent for treating primary hepatic carcinoma |
| 04/10/2013 | CN103028005A Preparation method of anti-lumbago tablet and application thereof |
| 04/10/2013 | CN103027986A Traditional Chinese medicine ointment for treating tumors |
| 04/10/2013 | CN103027953A Extractive containing total meroterpenoid of psidium guajave dialdehyde, and preparation method and application thereof |
| 04/10/2013 | CN103027951A Purification method of cortex mori total flavonoids |
| 04/10/2013 | CN103027932A Cortex periplocae anti-tumor effective component extractive as well as preparation method and application thereof |
| 04/10/2013 | CN103027931A Hydnocarpus hainanensis anti-tumor effective component extractive as well as preparation method and application thereof |
| 04/10/2013 | CN103027930A Biomass composition capable of forming and slowly releasing short-molecular polysaccharide, preparation method and preparation thereof |
| 04/10/2013 | CN103027929A Anti-tumor traditional Chinese medicine preparation and preparation method thereof |
| 04/10/2013 | CN103027924A Application of trichoderma pseudokoningii exopolysaccharide as medicine for treating gastric cancer |
| 04/10/2013 | CN103027897A Method for preparing monodispersity hydrophobic drug nanoparticles by template method |
| 04/10/2013 | CN103027893A Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 04/10/2013 | CN102633760B Isofraxidin crystalline compound and glabrous sarcandra herb dispersible tablets and dropping pills containing isofraxidin crystalline compound |
| 04/10/2013 | CN102552137B Triptolide fat emulsion injection and preparation method thereof |
| 04/10/2013 | CN102429890B Medicinal composition containing cells and application thereof |
| 04/10/2013 | CN102408973B Rhizoma polygonati health wine and preparation method thereof |
| 04/10/2013 | CN102408472B Bt (Bacillus Thuringiensis) protein Cry62Aa1 and coding gene as well as application thereof |
| 04/10/2013 | CN102399666B Ginseng wine and production technology thereof |
| 04/10/2013 | CN102397554B Tumor-targeting double-drug carrying and delivery system and preparation method thereof |